Simbaqueba Clavijo, C.; Odaro, O.; Gandhi, A.; Koom-Dadzie, K.; Musaelyan, A.; Dickson, K.; Chua, R.; Bhise, V.; Amoateng, M.; Tomy, S.;
et al. Immunotherapy-Related Adverse Events and Clinical Outcomes in Adult Solid-Tumor Patients Admitted to an Onco-Hospitalist Medicine Service. Cancers 2025, 17, 403.
https://doi.org/10.3390/cancers17030403
AMA Style
Simbaqueba Clavijo C, Odaro O, Gandhi A, Koom-Dadzie K, Musaelyan A, Dickson K, Chua R, Bhise V, Amoateng M, Tomy S,
et al. Immunotherapy-Related Adverse Events and Clinical Outcomes in Adult Solid-Tumor Patients Admitted to an Onco-Hospitalist Medicine Service. Cancers. 2025; 17(3):403.
https://doi.org/10.3390/cancers17030403
Chicago/Turabian Style
Simbaqueba Clavijo, Cesar, Orhue Odaro, Ayush Gandhi, Kwame Koom-Dadzie, Arine Musaelyan, Kodwo Dickson, Rosalie Chua, Viraj Bhise, Magdelene Amoateng, Sophy Tomy,
and et al. 2025. "Immunotherapy-Related Adverse Events and Clinical Outcomes in Adult Solid-Tumor Patients Admitted to an Onco-Hospitalist Medicine Service" Cancers 17, no. 3: 403.
https://doi.org/10.3390/cancers17030403
APA Style
Simbaqueba Clavijo, C., Odaro, O., Gandhi, A., Koom-Dadzie, K., Musaelyan, A., Dickson, K., Chua, R., Bhise, V., Amoateng, M., Tomy, S., Leal Alviarez, D., Phyu, E. M., Bogdanich, I., Andersen, C., Sheshadri, A., Palaskas, N. L., Halm, J., & Manzano, J.
(2025). Immunotherapy-Related Adverse Events and Clinical Outcomes in Adult Solid-Tumor Patients Admitted to an Onco-Hospitalist Medicine Service. Cancers, 17(3), 403.
https://doi.org/10.3390/cancers17030403
